drugset / Trial / NCT00894647

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

NCT00894647

Phase 3 Completed 247 enrolled Graceway Pharmaceuticals, LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate the efficacy and safety of imiquimod cream versus placebo cream when used after cryosurgery in the treatment of actinic keratoses (AKs).

Timeline

Start
2009-05
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Imiquimod Other / unclassified 18.75 mg Topical

Indications